These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37172332)

  • 41. Combination of statins and hormone replacement therapy in postmenopausal women is associated with increased bone mineral density.
    De Leo V; Morgante G; la Marca A; Lanzetta D; Cobellis L; Petraglia F
    Gynecol Endocrinol; 2003 Aug; 17(4):329-32. PubMed ID: 14503978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women.
    Orr-Walker BJ; Evans MC; Clearwater JM; Horne A; Grey AB; Reid IR
    Arch Intern Med; 2000 Jul; 160(14):2161-6. PubMed ID: 10904459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial.
    Chiechi LM; Secreto G; D'Amore M; Fanelli M; Venturelli E; Cantatore F; Valerio T; Laselva G; Loizzi P
    Maturitas; 2002 Aug; 42(4):295-300. PubMed ID: 12191852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention and treatment of osteoporosis in women with breast cancer.
    Mincey BA; Moraghan TJ; Perez EA
    Mayo Clin Proc; 2000 Aug; 75(8):821-9. PubMed ID: 10943237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society.
    Menopause; 2021 Sep; 28(9):973-997. PubMed ID: 34448749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Postmenopausal osteoporosis and alendronate.
    Pérez-López FR
    Maturitas; 2004 Jul; 48(3):179-92. PubMed ID: 15207883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluorosis increases the risk of postmenopausal osteoporosis by stimulating interferon γ.
    Lv YG; Kang L; Wu G
    Biochem Biophys Res Commun; 2016 Oct; 479(2):372-379. PubMed ID: 27644876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Shilajit extract reduces oxidative stress, inflammation, and bone loss to dose-dependently preserve bone mineral density in postmenopausal women with osteopenia: A randomized, double-blind, placebo-controlled trial.
    Pingali U; Nutalapati C
    Phytomedicine; 2022 Oct; 105():154334. PubMed ID: 35933897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
    Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y
    Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Osteoporosis: a review and its dental implications.
    Mattson JS; Cerutis DR; Parrish LC
    Compend Contin Educ Dent; 2002 Nov; 23(11):1001-4, 1006, 1008 passim; quiz 1014. PubMed ID: 12526189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estrogen therapy for postmenopausal osteoporosis.
    Fitzpatrick LA
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):705-19. PubMed ID: 17117296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relation of estrogen receptor-alpha gene polymorphism and hormone replacement therapy to fall risk and muscle strength in early postmenopausal women.
    Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Partanen J; Mäenpää PH
    Ann Med; 2002; 34(1):64-72. PubMed ID: 12014437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of phytoestrogens in the prevention and treatment of osteoporosis in ovarian hormone deficiency.
    Arjmandi BH
    J Am Coll Nutr; 2001 Oct; 20(5 Suppl):398S-402S; discussion 417S-420S. PubMed ID: 11603649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women.
    Harris ST; Eriksen EF; Davidson M; Ettinger MP; Moffett AH; Baylink DJ; Crusan CE; Chines AA
    J Clin Endocrinol Metab; 2001 May; 86(5):1890-7. PubMed ID: 11344179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis.
    Wimalawansa SJ
    Am J Med; 1998 Mar; 104(3):219-26. PubMed ID: 9552083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis.
    de Villiers TJ
    Climacteric; 2010 Jun; 13(3):210-8. PubMed ID: 20184423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors.
    Cepa M; Vaz C
    Acta Reumatol Port; 2015; 40(4):323-30. PubMed ID: 26922195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evidence of hormone replacement therapy for osteoporosis].
    Tarakida A; Higuchi T; Mizunuma H
    Clin Calcium; 2008 Oct; 18(10):1434-41. PubMed ID: 18830040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An economic analysis of hormone replacement therapy for the prevention of fracture in young postmenopausal women.
    Lamy O; Krieg MA; Burckhardt P; Wasserfallen JB
    Expert Opin Pharmacother; 2003 Sep; 4(9):1479-88. PubMed ID: 12943477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimising antiresorptive therapies in postmenopausal women: why do we need to give due consideration to the degree of suppression?
    Karsdal MA; Qvist P; Christiansen C; Tankó LB
    Drugs; 2006; 66(15):1909-18. PubMed ID: 17100403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.